DPOP: About DPOP
The Division of Pharmaceutical Outcomes and Policy (DPOP) conducts research using innovative methods to inform drug policy and improve patient outcomes. With nine faculty members, it is one of the smallest divisions in the School of Pharmacy. Faculty support the School’s teaching mission by participation in the professional and doctoral programs. Faculty support the School’s service mission by participating on committees at the School, University, State, national and international levels. The Division’s strategic plan derives from the opportunities and challenges that face our faculty and staff. We are pleased to participate in the School’s strategic planning process and do so with hopes of expanding the capacity to conduct our widely-recognized research, quality teaching, and commitment to service.
MissionThe mission of the Division of Pharmaceutical Outcomes and Policy is to improve medication use and healthcare through innovative health outcomes research, post-graduate training and professional education, and service. This division focuses its research and teaching in pharmacoepidemiology, pharmacoeconomics, behavioral sciences, and health services research as contributors to pharmaceutical outcomes research. VisionWe will be recognized as innovators and leaders in pharmaceutical |
DPOP is one of the few programs in the country, housed in a school of pharmacy, whose faculty have active research programs in the field of pharmaceutical outcomes and policy. Research in this area has grown considerably over the past decade. This increased interest has been stimulated by two primary factors: (1) the rising cost of pharmaceuticals coupled with the need to justify this expenditure in terms of improved health outcomes, and (2) increased recognition that medications can have deleterious effects as well as therapeutic benefits. Recently, the implementation of Medicare Part D has placed the importance of pharmaceuticals, comparative effectiveness, and medication therapy management services at the forefront of debates on healthcare reform. In order for pharmacy to become a key leader and stakeholder, it will need to train pharmaceutical scientists who can conduct scientifically rigorous studies that inform policy decisions. Such scientists should be anchored in important scientific, ethical, and professional issues. DPOP is exceptionally well-positioned to take on this challenge.